VEINSOUND : the Innovation in Varicose Veins Treatment

Our company

Offer a long awaited revolution in varicose veins treatment.

Propel the field of phlebology forward by introducing groundbreaking non-invasive non-thermal technology for the treatment of superficial venous diseases.

Our vision & objectives

We aim to provide a revolutionary technology for the in-office treatment of varicose veins.

Our values

Convinced that innovation is the driving force behind medical progress, we continuously explore new approaches to enhance the effectiveness, safety, and comfort of treatments for patients. We push the boundaries of phlebology by developing our advanced non-invasive and non-thermal technology for the treatment of varicose veins.

Innovation

It is at the heart of everything we do at Veinsound. We adhere to the highest ethical standards in our research, development and business practices. Our commitment to honesty and transparency builds trust with our patients, partners and investors. This enables us to offer reliable and effective solutions for the treatment of venous disease.

Ethics & Integrity

At Veinsound, passion drives us to constantly innovate and excel in non-invasive medical technology. Our team is fully committed to improving the quality of life of people suffering from varicose veins and facilitate the work of doctors. This fuels our pursuit of excellence and keeps us at the forefront of medical advances.

Passion

Veinsound places a strong emphasis on human values, because we want our success to be based on the well-being and respect of individuals. We foster a culture of empathy, compassion and respect within our team and in our interactions with our partners. Our patient-centred approach ensures that we put the needs and comfort of those we serve first.

Human values

Diligence is a hallmark of Veinsound's approach to innovation and patient care. Our team works meticulously to develop and refine cutting-edge technologies, ensuring that our solutions are safe, effective and reliable. We are committed to rigorous testing and continuous improvement, striving for quality in all aspects of our work.

Diligence

Corporate Social Responsibility (CSR) is an integral part of our mission at Veinsound. We are committed to making a positive impact on society by promoting sustainable practices and contributing to the advancement of healthcare. Our CSR initiatives reflect our commitment to ethical business practices.

Corporate Social Responsibility

Our Team

The leadership team at Veinsound consists of experienced professionals from the robotics and medical devices sector, covering management, technology, clinical, and regulatory affairs. The crew is complemented by scientific experts from INSERM U1032 and international medical advisors. We are an experienced group at the head of a disruptive, dynamic and resolutely innovative start-up!

Board of Directors

Stéphane LAVALLEE

Chairman of the Board

Stéphane Lavallée, PhD, is an entrepreneur specializing in “smart” medical devices. After co-founding and leading Praxim, he founded a network of startups specializing in medtech as well as multiple startups that were successfully acquired including Blue Ortho. He has also established collaborations with medical companies, hospitals, surgeons and institutions, providing a network of deep expertise. Stéphane is the founder of eCential Robotics, Orthotaxy (acquired by Depuy Synthes, a J&J company).

Bernard GREILLIER

Founder & Technical Advisor

Since the beginning of his career, Bernard has been involved in high technology projects. Passionate about the medical world since his time at TECHNOMED, he caught the start-up virus and followed his path in the creation of new products with his skill and curiosity for new technologies. In 2017, Bernard founded Veinsound with his two partners, Thomas and Didier.

Thomas CHARREL

President & CEO, Co-Founder

Thomas, PhD, joined the team at the company's inception in 2017. After experiences in High-Intensity Focused Ultrasound startups with EYETECHCARE he successfully launched the product in China. Thomas discovers the vascular market at MEDTRONIC as New-Product Development Leader, and naturally identified the potential of HIFU for venous treatment.